FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018563723> ?p ?o ?g. }

• W2018563723 endingPage "116" @default.
• W2018563723 startingPage "114" @default.
• W2018563723 abstract "Vox SanguinisVolume 70, Issue 2 p. 114-116 New Strip Immunoblot for the Confirmation of HTLV-I/II Infection H. Vrielink, Corresponding Author H. Vrielink Red Cross Blood Bank AmsterdamRed Cross Blood Bank Amsterdam PO 9137 NL-1006 AC Amsterdam (The Netherlands)Search for more papers by this authorH.L. Zaaijer, H.L. Zaaijer Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The NetherlandsSearch for more papers by this authorC.L. van der Poel, C.L. van der Poel Red Cross Blood Bank AmsterdamSearch for more papers by this authorS. Quan, S. Quan Chiron Corporation, Emeryville, Calif.Search for more papers by this authorH.T.M. Cuypers, H.T.M. Cuypers Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The NetherlandsSearch for more papers by this authorM. Rios, M. Rios New York Blood Center, New York, N.Y., USASearch for more papers by this authorP.N. Lelie, P.N. Lelie Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The NetherlandsSearch for more papers by this authorA. Polito, A. Polito Chiron Corporation, Emeryville, Calif.Search for more papers by this authorK. Sra, K. Sra Chiron Corporation, Emeryville, Calif.Search for more papers by this authorR. DiNello, R. DiNello Chiron Corporation, Emeryville, Calif.Search for more papers by this authorS. Pichuantes, S. Pichuantes Chiron Corporation, Emeryville, Calif.Search for more papers by this authorD. Larson, D. Larson Chiron Corporation, Emeryville, Calif.Search for more papers by this authorH.W. Reesink, H.W. Reesink Red Cross Blood Bank Amsterdam Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The NetherlandsSearch for more papers by this author H. Vrielink, Corresponding Author H. Vrielink Red Cross Blood Bank AmsterdamRed Cross Blood Bank Amsterdam PO 9137 NL-1006 AC Amsterdam (The Netherlands)Search for more papers by this authorH.L. Zaaijer, H.L. Zaaijer Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The NetherlandsSearch for more papers by this authorC.L. van der Poel, C.L. van der Poel Red Cross Blood Bank AmsterdamSearch for more papers by this authorS. Quan, S. Quan Chiron Corporation, Emeryville, Calif.Search for more papers by this authorH.T.M. Cuypers, H.T.M. Cuypers Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The NetherlandsSearch for more papers by this authorM. Rios, M. Rios New York Blood Center, New York, N.Y., USASearch for more papers by this authorP.N. Lelie, P.N. Lelie Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The NetherlandsSearch for more papers by this authorA. Polito, A. Polito Chiron Corporation, Emeryville, Calif.Search for more papers by this authorK. Sra, K. Sra Chiron Corporation, Emeryville, Calif.Search for more papers by this authorR. DiNello, R. DiNello Chiron Corporation, Emeryville, Calif.Search for more papers by this authorS. Pichuantes, S. Pichuantes Chiron Corporation, Emeryville, Calif.Search for more papers by this authorD. Larson, D. Larson Chiron Corporation, Emeryville, Calif.Search for more papers by this authorH.W. Reesink, H.W. Reesink Red Cross Blood Bank Amsterdam Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The NetherlandsSearch for more papers by this author First published: February 1996 https://doi.org/10.1111/j.1423-0410.1996.tb01303.xCitations: 7AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Vrielink H., van der Poel CL, Reesink WH: Efticacy of selected versus random blood donor screening for anti-HTLV-I antibodies. Vox Sang 1995; 68: 251–252. 2 Zaaijer HL, Cuypers HTM, Dudok de Wit C., Lelie PN: Results of 1-year screening of donors in the Netherlands for human T-lymphotropic virus (HTLV) type 1: Significance of Western blot patterns for confirmation of HTLV infection. Transfusion 1994: 34: 877–880. 3 Brodine SK, Kaime EM, Roberts C., Turnicky RP, Lal RB: Simultaneous confirmation and differentiation of human T-lymphotropic virus types I and II infection by modified Western blot containing recombinant envelope glycoproteins. Transfusion 1993; 33: 925–929. 4 Garin B., Gosselin S., de Thé G., Gessain A.: HTLV-I/II infection in a high viral endemic area of Zaire, Central Africa: Comparative evaluation of serology, PCR, and significance of indeterminate Western blot pattern. J Med Virol 1994; 44: 104–109. 5 Inaba S., Sato H., Okochi K., Fukada K., Tokunaga K., Kiyokawa H., Maeda Y.: Prevention of transmission of human T-lymphotropic virus type I (HTLV-I) through transfusion, by donor screening with antibody to the virus. Transfusion 1989; 29: 7–11. 6 Reesink HW, Vrielink H., Zaaijer HL, Woerdeman M., van der Poel CL, Lelie PN, Cuypers HTM: Evaluation of a new HTLV-I/II PCR: Amplicor HTLV-I/II test. Transfusion 1994; 34 (suppl): S191. 7 Lee HH, Swanson P., Rosenblatt JD, Chen ISY, Sherwood WC, Smith DE, Tegtrneier GE, Fernando LP, Fang CT, Osarne M., Kleinman SH: Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors. Lancet 1991; 337: 1435–1439. Citing Literature Volume70, Issue2February 1996Pages 114-116 ReferencesRelatedInformation" @default.
• W2018563723 created "2016-06-24" @default.
• W2018563723 creator A5004048701 @default.
• W2018563723 creator A5022638142 @default.
• W2018563723 creator A5026504654 @default.
• W2018563723 creator A5028479016 @default.
• W2018563723 creator A5051350839 @default.
• W2018563723 creator A5055608994 @default.
• W2018563723 creator A5057195518 @default.
• W2018563723 creator A5058098354 @default.
• W2018563723 creator A5068795488 @default.
• W2018563723 creator A5070630828 @default.
• W2018563723 creator A5086450911 @default.
• W2018563723 creator A5091240947 @default.
• W2018563723 creator A5091250605 @default.
• W2018563723 date "1996-02-01" @default.
• W2018563723 modified "2023-10-09" @default.
• W2018563723 title "New Strip Immunoblot for the Confirmation of HTLV-I/II Infection" @default.
• W2018563723 cites W1975441750 @default.
• W2018563723 cites W2000493448 @default.
• W2018563723 cites W2030169750 @default.
• W2018563723 cites W2118337629 @default.
• W2018563723 cites W2132822179 @default.
• W2018563723 cites W2146269477 @default.
• W2018563723 doi "https://doi.org/10.1111/j.1423-0410.1996.tb01303.x" @default.
• W2018563723 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8801759" @default.
• W2018563723 hasPublicationYear "1996" @default.
• W2018563723 type Work @default.
• W2018563723 sameAs 2018563723 @default.
• W2018563723 citedByCount "13" @default.
• W2018563723 countsByYear W20185637232013 @default.
• W2018563723 crossrefType "journal-article" @default.
• W2018563723 hasAuthorship W2018563723A5004048701 @default.
• W2018563723 hasAuthorship W2018563723A5022638142 @default.
• W2018563723 hasAuthorship W2018563723A5026504654 @default.
• W2018563723 hasAuthorship W2018563723A5028479016 @default.
• W2018563723 hasAuthorship W2018563723A5051350839 @default.
• W2018563723 hasAuthorship W2018563723A5055608994 @default.
• W2018563723 hasAuthorship W2018563723A5057195518 @default.
• W2018563723 hasAuthorship W2018563723A5058098354 @default.
• W2018563723 hasAuthorship W2018563723A5068795488 @default.
• W2018563723 hasAuthorship W2018563723A5070630828 @default.
• W2018563723 hasAuthorship W2018563723A5086450911 @default.
• W2018563723 hasAuthorship W2018563723A5091240947 @default.
• W2018563723 hasAuthorship W2018563723A5091250605 @default.
• W2018563723 hasConcept C161191863 @default.
• W2018563723 hasConcept C17744445 @default.
• W2018563723 hasConcept C194828623 @default.
• W2018563723 hasConcept C199539241 @default.
• W2018563723 hasConcept C2778348171 @default.
• W2018563723 hasConcept C2994072243 @default.
• W2018563723 hasConcept C41008148 @default.
• W2018563723 hasConcept C71924100 @default.
• W2018563723 hasConceptScore W2018563723C161191863 @default.
• W2018563723 hasConceptScore W2018563723C17744445 @default.
• W2018563723 hasConceptScore W2018563723C194828623 @default.
• W2018563723 hasConceptScore W2018563723C199539241 @default.
• W2018563723 hasConceptScore W2018563723C2778348171 @default.
• W2018563723 hasConceptScore W2018563723C2994072243 @default.
• W2018563723 hasConceptScore W2018563723C41008148 @default.
• W2018563723 hasConceptScore W2018563723C71924100 @default.
• W2018563723 hasIssue "2" @default.
• W2018563723 hasLocation W20185637231 @default.
• W2018563723 hasLocation W20185637232 @default.
• W2018563723 hasOpenAccess W2018563723 @default.
• W2018563723 hasPrimaryLocation W20185637231 @default.
• W2018563723 hasRelatedWork W1982533836 @default.
• W2018563723 hasRelatedWork W1995515455 @default.
• W2018563723 hasRelatedWork W2080531066 @default.
• W2018563723 hasRelatedWork W2510741825 @default.
• W2018563723 hasRelatedWork W2513992041 @default.
• W2018563723 hasRelatedWork W2748952813 @default.
• W2018563723 hasRelatedWork W2899084033 @default.
• W2018563723 hasRelatedWork W3031052312 @default.
• W2018563723 hasRelatedWork W3032375762 @default.
• W2018563723 hasRelatedWork W4239394745 @default.
• W2018563723 hasVolume "70" @default.
• W2018563723 isParatext "false" @default.
• W2018563723 isRetracted "false" @default.
• W2018563723 magId "2018563723" @default.
• W2018563723 workType "article" @default.